This inventor holds 1 USPTO granted patent. Top assignee: Chengdu Di'ao Jiuhong Pharmaceutical Factor. Active years: 2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2013
Title: Innovations of Junjian Liu in Pharmaceutical Development
Introduction
Junjian Liu is a notable inventor based in Sichuan, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of medicaments aimed at increasing leucocytes and platelets. His innovative approach utilizes natural compounds, making his work both accessible and impactful.
Latest Patents
Junjian Liu holds a patent for the "Use of ursolic acid saponin, oleanolic acid saponin in preparation of increasing leucocytes and/or platelet medicine." This invention provides a method for preparing medicaments that effectively increase leucocytes and/or platelets. The patent highlights the use of inexpensive and readily available natural plant compounds, specifically ursolic acid and oleanolic acid, which are modified to enhance their medicinal properties. Pharmacological tests have demonstrated that the compounds exhibit significant activity in boosting leucocyte and platelet counts.
Career Highlights
Junjian Liu is associated with Chengdu Di'ao Jiuhong Pharmaceutical Factory, where he applies his expertise in pharmaceutical innovation. His work has not only contributed to the advancement of medical treatments but also emphasizes the importance of utilizing natural resources in drug development.
Collaborations
Junjian Liu collaborates with esteemed colleagues such as Jianxin Ji and Xiangyang Peng. Their combined efforts in research and development have furthered the understanding and application of natural compounds in medicine.
Conclusion
Junjian Liu's innovative work in the pharmaceutical industry showcases the potential of natural compounds in enhancing health outcomes. His contributions are paving the way for more effective and accessible medical treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile